Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rank in Stocks #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Share Price
$0.03808538
Market Cap
$14.04M
Change (1 day)
-3.57%
Change (1 year)
6.63%
Country
AU
Trade BCAL Diagnostics Limited (BDX)

Category

Stock split history for BCAL Diagnostics Limited (BDX)
BCAL Diagnostics Limited stock (symbol: BDX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 18, 2026.
One BDX share bought prior to Aug 18, 2026 would equal to 0 BDX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US